At BioLab we perform the biological evaluation of synthetic and natural compounds against a panel of representative human solid tumor cell lines. From this test, we determine if compounds are active and/or of interest to go into depth. We try to shed light on the mechanism of action by studying the effects of the products at a molecular level. Our ultimate goal is to identify the biological target(s) at which the active compound is directed. Through collaboration with external partners, we shuttle these molecules to increase their bioavailability, promote their blood circulation and cell internalization, reduce drug resistance and induce a controlled drug release at the target site. While the core activities of BioLab remain in this specific topic, in the past recent years we have expanded our capacities.

At present, five divisions comprise BioLab, namely Bioevaluation, Synthesis, Computation, Bioprospection and Drug Delivery.


Research at BioLab